Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options
- PMID: 26356634
- PMCID: PMC4548351
- DOI: 10.14218/JCTH.2015.00007
Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options
Abstract
Drug-induced liver injury (DILI) is a rare but potentially life threatening adverse drug reaction. DILI may mimic any morphologic characteristic of acute or chronic liver disease, and the histopathologic features of DILI may be indistinguishable from those of other causes of liver injury, such as acute viral hepatitis. In this review article, we provide an update on causative agents, clinical features, pathogenesis, diagnosis modalities, and outcomes of DILI. In addition, we review results of recently reported genetic studies and updates on pharmacological and invasive treatments.
Keywords: DILI; Hepatotoxicity; Treatment.
Conflict of interest statement
Figures
References
-
- Holt MP, Ju C. Mechanisms of drug-induced liver injury. AAPS J. 2006;8:E48–E54. 10.1208/aapsj080106. - DOI - PMC - PubMed
-
- Lee WM. Acute liver failure in the United States. Semin Liver Dis. 2003;23:217–226. 10.1055/s-2003-42641. - DOI - PubMed
-
- Lewis JH. Drug-induced liver disease. Med Clin North Am. 2000;84:1275–1311. x. - PubMed
-
- Au JS, Navarro VJ, Rossi S. Review article: Drug-induced liver injury--its pathophysiology and evolving diagnostic tools. Aliment Pharmacol Ther. 2011;34:11–20. 10.1111/j.1365-2036.2011.04674.x. - DOI - PubMed
-
- Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36:451–455. 10.1053/jhep.2002.34857. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources